The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Fabien Praz

Showing 1-15 of 15 articles
Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis
Schlotter F, Miura M, Kresoja K, Alushi B, Alessandrini H, Attinger-Toller A, Besler C, Biasco L, Braun D, Brochet E, Connelly K, de Bruijn S, Denti P, Estevez-Loureiro R, Fam N, Gavazzoni M, Himbert D, Ho E, Juliard J, Kalbacher D, Kaple R, Kreidel F, Latib A, Lubos E, Ludwig S, Mehr M, Monivas V, Nazif T, Nickenig G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Rommel K, Schäfer U, Schofer J, Sievert H, Tang G, Thiele H, Unterhuber M, Vahanian A, von Bardeleben R, von Roeder M, Webb J, Weber M, Wild M, Windecker S, Zuber M, Hausleiter J, Maisano F, Leon M, Hahn R, Lauten A, Taramasso M, Lurz P
July 20, 2021 | 10.4244/EIJ-D-21-00191
Coronary interventions
Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition
Gragnano F, Spirito A, Corpataux N, Vaisnora L, Galea R, Gargiulo G, Siontis G, Praz F, Lanz J, Billinger M, Hunziker L, Stortecky S, Pilgrim T, Bär S, Ueki Y, Capodanno D, Urban P, Pocock S, Mehran R, Heg D, Windecker S, Räber L, Valgimigli M
June 8, 2021 | 10.4244/EIJ-D-21-00181
Transcatheter tricuspid valve treatment: does annular reduction make a difference?
Praz F, Brugger N
February 5, 2021 | 10.4244/EIJV16I15A219
Transcatheter treatment of multivalvular heart disease
Winkel M, Brugger N, Hunziker L, Windecker S, Praz F
November 20, 2020 | 10.4244/EIJ-D-20-00244
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L
August 28, 2020 | 10.4244/EIJ-D-20-00052
Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography
Xiong T, Pighi M, Thériault-Lauzier P, Leipsic J, Spaziano M, Martucci G, Buithieu J, Mousavi N, Pilgrim T, Praz F, Windecker S, Chen M, Piazza N
November 15, 2019 | 10.4244/EIJ-D-19-00618
Interventions for stroke
Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale
Susuri N, Obeid S, Ulmi M, Siontis G, Wahl A, Windecker S, Nietlispach F, Meier B, Praz F
September 20, 2017 | 10.4244/EIJ-D-17-00061
Interventions for valvular disease
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation
Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T
April 7, 2017 | 10.4244/EIJ-D-16-00790
Interventions for valvular disease
Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system
Praz F, Moschovitis A, Stortecky S, Pilgrim T, Eberle B, Windecker S
October 20, 2016 | 10.4244/EIJV12I9A194
Interventions for valvular disease
Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation
O’Sullivan C, Spitzer E, Heg D, Praz F, Stortecky S, Huber C, Carrel T, Pilgrim T, Windecker S
July 20, 2016 | 10.4244/EIJV12I4A83
Interventions for valvular disease
Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve
Wenaweser P, Stortecky S, Schütz T, Praz F, Gloekler S, Windecker S, Elsasser A
May 16, 2016 | 10.4244/EIJV12I1A13
A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)
Puricel S, Arroyo D, Goy J-J, Praz F, Palhais N, Wahl A, Stauffer J-C, Togni M, Berger A, Meier B, Cook S
June 19, 2015 | 10.4244/EIJY14M05_05
Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making
O’Sullivan C, Praz F, Stortecky S, Windecker S, Wenaweser P
September 27, 2014 | 10.4244/EIJV10SUA9
Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device
Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M
September 27, 2014 | 10.4244/EIJV10SUA18
Cerebral protection devices for transcatheter aortic valve implantation: is better the enemy of good?
Praz F, Nietlispach F
September 15, 2013 | 10.4244/EIJV9SSA26

Latest news

NEW ISSUE
EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…
July 20, 2021
Editorial
Treatment of secondary mitral regurgitation in patients with heart failure
Marco Metra et al
July 27, 2021
JAA
This Week's JAA's: DLMC in CTO-PCI, Membranous Septum Morphology and TAVI ...
August 3, 2021
Editorial
Coronary flow capacity: where to next?
Nils P. Johnson
July 20, 2021
Ahead of print
Joint EAPCI/ACVC expert consensus document on pVADs
July 20, 2021
NEW
EuroIntervention's new impact factor!
July 1, 2021
STATE OF THE ART
Completeness of Revascularisation in ACS Patients with Multivessel Disease
Valeria Paradies et al.
June 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke